The president said the cost of the drug should be much lower for Americans once negotiations with Novo Nordisk had concluded.

The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...

President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and ...

Novo Nordisk shares fell on Friday after Donald Trump vowed to sharply lower the price of its popular weight loss drug ...

Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.

Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.” ...

COPENHAGEN (Reuters) -Novo Nordisk shares fell as much as 6.4% in early Friday trade after U.S. President Donald Trump ...

During a press conference, Trump specifically mentioned Ozempic, referring to it as "the fat loss drug" when asked about a $1 ...

Shares of Danish pharmaceutical giant Novo Nordisk are trading lower Friday morning, continuing an after-hours slide that ...

In a significant stride for chronic disease management, FDA granted approvals for Roche’s lupus nephritis treatment and Novo Nordisk’s cardiovascular-risk-reducing oral semaglutide for adults with ...

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss ...

Danish drugmaker Novo Nordisk (NVO) slipped 6% in early trading on Friday after U.S. President Donald Trump said on Thursday ...